• Info
  • Insider Ownership

Insider Trading & Ownership of Catherine Coste

Location
Danville, CA
Summary
The estimated net worth of Catherine Coste is at least $379,644 dollars as of 26 Feb 2026. Catherine Coste is the Director of BIOLIFE SOLUTIONS INC and owns shares of BIOLIFE SOLUTIONS INC (BLFS) stock worth about $313.2K. Catherine Coste is the Director of BIOMERICA INC and owns shares of BIOMERICA INC (BMRA) stock worth about $39.9K. Catherine Coste is the Director of MINERVA SURGICAL INC and owns shares of MINERVA SURGICAL INC (UTRS) stock worth about $26.5K.
Signature
/s/ Catherine Coste
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Catherine Coste and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Catherine Coste has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $379,644.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BIOLIFE SOLUTIONS INC ($313,207).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Catherine Coste

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BLFS BIOLIFE SOLUTIONS INC Director $313,207 24 Feb 2026
BMRA BIOMERICA INC Director $39,925 13 Dec 2024
UTRS MINERVA SURGICAL INC Director $26,512 10 Jun 2022
RNLXY, RENXF Renalytix plc Director 20 Nov 2023

Insider Transactions Reported by Catherine Coste:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.